ANIXA BIOSCIENCES, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2014-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2014-07-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2013-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2013-07-31 was $603.36K.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $2.74M, a 102.11% increase from fiscal 2013.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, conversion of convertible securities for fiscal 2013 was $1.35M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2014-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $2.74M 10-K · filed 2015-12-23 |
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | |
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $1.35M 10-K · filed 2015-01-29 |
| 2013-07-31 | $603.36K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |